Events Calendar

Mon
Tue
Wed
Thu
Fri
Sat
Sun
M
T
W
T
F
S
S
26
27
28
29
30
31
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
17
18
20
21
22
24
25
26
27
28
29
30
1
2
3
4
5
6
BARDA Industry Day
2020-10-27    
12:00 am
Organized by BARDA BARDA Industry Day is the annual meeting held to increase potential partner’s awareness of U.S. Government medical countermeasure priorities, interact with BARDA [...]
The Future of Insurance USA
2020-11-16 - 2020-11-18    
All Day
We’re excited to announce today the launch of The Future of Insurance USA (November 16-18 2020), an online 3-day conference by Reuters Events. The Future [...]
Geneva Health Forum 2020
2020-11-16 - 2020-11-18    
12:00 am
Geneva Health Forum 2020 The 8th edition of the Geneva Health Forum will take place from 16-18 November 2020. The thematic of the year will [...]
19 Nov
2020-11-19 - 2020-11-20    
12:00 am
The stage is set for a paradigm shift in healthcare. The opportunity exists to redefine healthcare in a way that transforms patient outcomes, drives efficiency [...]
The 2nd Saudi International Pharma Expo
2020-11-23 - 2020-11-24    
All Day
ABOUT THE 2ND SAUDI INTERNATIONAL PHARMA EXPO SAUDI INTERNATIONAL PHARMA EXPO offers you an EXCELLENT opportunity to expand your business in Saudi Arabia and international [...]
World Congress on Medical Toxicology
2020-12-01 - 2020-12-02    
12:00 am
World Congress on Medical Toxicology Medical Toxicology Pharma 2020 provides a global platform to meet and develop interpersonal relationship with the world’s leading toxicologists, pharmacologists, [...]
01 Dec
2020-12-01 - 2020-12-02    
All Day
International Conference on Food Technology & Beverages” at Kyoto, Japan in the course of Kyoto, Japan, December, 01-02, 2020 Theme of the Food Tech 2020 [...]
Biomedical, Bio Pharma and Clinical Research
2020-12-03 - 2020-12-04    
12:00 am
Biomedical, Bio Pharma and Clinical Research Conference Series LLC LTD cordially invites you to be a part of “2nd International Conference on Biomedical, Bio Pharma [...]
Events on 2020-10-27
BARDA Industry Day
27 Oct 20
Events on 2020-11-16
Events on 2020-11-19
Events on 2020-11-23
The 2nd Saudi International Pharma Expo
23 Nov 20
King Abdullah
Events on 2020-12-03
Articles

Aug 21 : Stage 2 “Can Be Done,” says the First Critical Access Hospital to Attest

hipaa compliance

by Gabriel Perna

While the number of eligible providers (EPs) and eligible hospitals (EHs) that have attested to Stage 2 of meaningful use continues to lag behind, one rural hospital found a way to get it done.

Odessa Memorial Healthcare Center, is a 25-bed critical access hospital (CAH) in Odessa, Wash., a tiny hamlet located approximately 70 miles to the west of Spokane with a population of less than 1,000. According to Megan Shepard, R.N., clinical services director at Odessa Memorial, the hospital’s volume is so low that most of the managers oversee multiple departments and projects.

In fact, Shepard says the hospital doesn’t even have an IT department. Shepard was part of the electronic health record (EHR) team that has helped the hospital attest to meaningful use Stages 1 and 2. It also used outside assistance.  “INHS (Inland Northwest Health Services) was our IT department. They were the ones who have been doing our IT support for meaningful use and information gathering to reach the goals,” Shepard says.

INHS is a Spokane-based nonprofit corporation made up of member hospitals in the region that collaborate on services such as IT guidance. INHS has a division, Engage, which acts as a health IT software vendor to organizations like Odessa, providing EHR and meaningful use guidance. Engage has a partnership with the Westwood, Mass.-based Meditech, and administers the company’s clinical and finance software for end-users, especially at rural hospitals like Odessa.

Despite utilizing this kind of assistance, Odessa had its struggles. It still had to get patients to use its portal. This, Shepard confirms, was the hardest part of Stage 2, which requires EPs and EHs to have five percent of their patients view, download, and transmit their health data electronically.

Indeed, this seems to be what’s holding up most providers. A recent study by researchers, led by Julia Adler-Milstein, Ph.D. University of Michigan School of Public Health assistant professor of information, looked at adoption of EHR systems in hospitals since the enactment of the Health Information Technology for Economic and Clinical Health (HITECH). They found that a measly 10 percent of hospitals surveyed met the threshold for having patients view, download, and transmit their health information electronically. It had the lowest percent of adoption among every single Stage 2 measure by hospitals, just in front of the transitions of care measure.

“The hardest thing for us was getting patients interested in using the portal,” Shepard says. “The population we serve is elderly, many didn’t grow up using a computer, and many don’t even have email.”

This forced Odessa to recruit family members and directly engage with someone younger, especiallyif they had experience in using a computer. Because of the small staff, Shepard says it was easy to recruit providers and get them on board with this mission and the overall meaningful use project. In fact, she notes that a radiology technician calls ER patients every week and tries to see if they are interested in using the patient portal.

Despite this effort, it wasn’t easy to get past that five percent view, download, transmit threshold. Other meaningful use measures, Shepard says, were easier because it was simply building on top of Stage 1. Even the transitions of care measures weren’t as hard. “If you did [the other measures] well in Stage 1, it’s just a matter of the numbers increasing and the percentages increasing,” she notes.

Of course, for many, it’s more complex. In its most recent data release, the Centers for Medicare and Medicaid Services (CMS) indicated that 78 out of approximately 3,000 eligible hospitals have attested to Stage 2. Marcy Cheadle, R.N., the director of meaningful use and advanced clinicals for Engage, says that there is a lot up in the air in regards to Stage 2.

“From a pure canvas, check it off the list standpoint, Stage 2 is doable. However, from a can we make the information and usability case for clinicians and our patients meaningful, that’s yet to be determined,” says Cheadle. “We have a lot of work to do in analyzing information from Stage 2, particularly related to quality measures. We have a tremendous amount of work in understanding the transitions of care summary, the continuity-of-care document exchange, and quality data going to the federal government.”

Source